Figure 2.
Proportion of post-endoscopic retrograde cholangiopancreatography (ERCP) hyperamylasaemia occurrence among ERCP patients with a 25 mg vs 50 mg dose of rectal diclofenac administration.
Proportion of post-endoscopic retrograde cholangiopancreatography (ERCP) hyperamylasaemia occurrence among ERCP patients with a 25 mg vs 50 mg dose of rectal diclofenac administration.